In a patient with a urine culture growing >100,000 CFU/mL Enterococcus faecalis that is susceptible to ciprofloxacin, levofloxacin, and nitrofurantoin, and who has been receiving trimethoprim‑sulfamethoxazole (Bactrim) for 5 days, what is the recommended antibiotic therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switch Antibiotics Immediately – Bactrim is Ineffective Against Enterococcus faecalis

You must discontinue trimethoprim-sulfamethoxazole (Bactrim) immediately and switch to an appropriate antibiotic, as Enterococcus faecalis is intrinsically resistant to this agent despite appearing susceptible on standard laboratory testing. This is a critical clinical pitfall that can lead to treatment failure and potentially serious complications including bacteremia 1.

Why Bactrim Fails Against Enterococcus

Enterococci possess a unique ability to incorporate exogenous folates from their environment, completely bypassing the antifolate mechanism of trimethoprim-sulfamethoxazole 1, 2. While your laboratory may report the organism as "susceptible" using standard testing media, this does not predict clinical efficacy. In vivo, the MIC can increase up to 360-fold when tested in media containing urine 2. Clinical case reports document patients developing enterococcal bacteremia while on Bactrim therapy for UTI, despite in vitro susceptibility 1.

Recommended Treatment Options

Based on your susceptibility results showing sensitivity to ciprofloxacin, levofloxacin, and nitrofurantoin, here are your evidence-based options:

First-Line Choice: Nitrofurantoin 100 mg PO every 6 hours

  • Duration: 5-7 days 3, 4
  • Excellent activity against E. faecalis with 88-100% susceptibility rates 5, 6
  • Clinical and microbiological cure rates of 86-93% for uncomplicated UTI 3
  • Minimal collateral damage to gut flora
  • This is the preferred option for uncomplicated cystitis 4, 7

Alternative: Levofloxacin 750 mg PO daily

  • Duration: 5 days 3, 8
  • Highly effective with 90%+ cure rates 3
  • Reserve for cases where nitrofurantoin cannot be used (e.g., reduced renal function with CrCl <30 mL/min)
  • Consider ecological impact – fluoroquinolones should be preserved for more serious infections 3

If Complicated UTI or Pyelonephritis Suspected: Levofloxacin 750 mg daily for 5-7 days 3, 8

  • Use if patient has fever, flank pain, or systemic symptoms
  • May require initial IV dose if severely ill

Critical Clinical Considerations

Assess for complicated vs uncomplicated UTI:

  • Uncomplicated cystitis (dysuria, frequency, urgency without fever): Nitrofurantoin is ideal
  • Complicated UTI or pyelonephritis (fever, flank pain, systemic symptoms): Levofloxacin preferred
  • Male patients, catheterized patients, or those with urological abnormalities require longer treatment (14 days) 8, 7

Common pitfall to avoid: Do not rely on ciprofloxacin susceptibility alone without considering local resistance patterns. While your isolate shows susceptibility, fluoroquinolones should be reserved for more serious infections when other options exist 3.

Regarding the 5 days of Bactrim already given: This represents ineffective therapy. The organism has likely persisted despite treatment. Do not count these days toward your treatment duration with the new antibiotic.

Why Not Other Options?

  • Ampicillin/Amoxicillin: While E. faecalis is typically ampicillin-susceptible, this requires high-dose IV therapy (18-30g daily) for UTI 4 and is impractical for outpatient management
  • Fosfomycin: Single 3g dose is an option for uncomplicated UTI 4, but has lower microbiological cure rates (78%) compared to nitrofurantoin (86%) 3
  • Linezolid: Reserved for serious systemic enterococcal infections, not appropriate for uncomplicated UTI 4

Start appropriate therapy today – each additional day on ineffective treatment increases risk of ascending infection and complications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.